A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Hypercholesterolemia

Treatments: Behavioral: Self-Management System; Drug: MK0803, lovastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092846

2004_061

0803-084

Details and patient eligibility

About

The purpose of this study is to evaluate the ability of patients with intermediate risk of heart disease to appropriately use a Self-Management System.

Full description

The duration of treatment is 6 months.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 45+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Must be able to read and understand English without assistance.
• For Males: Minimum age 45 years and Maximum age N/A (No limit).
• For Females: Minimum age 55 years and Maximum age N/A (No limit).

Exclusion criteria

• Pregnant or nursing
• Drug allergy

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)